JP2012532739A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012532739A5 JP2012532739A5 JP2012520713A JP2012520713A JP2012532739A5 JP 2012532739 A5 JP2012532739 A5 JP 2012532739A5 JP 2012520713 A JP2012520713 A JP 2012520713A JP 2012520713 A JP2012520713 A JP 2012520713A JP 2012532739 A5 JP2012532739 A5 JP 2012532739A5
- Authority
- JP
- Japan
- Prior art keywords
- body member
- engineered
- nanoparticle body
- processed
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002105 nanoparticle Substances 0.000 claims description 53
- 239000002245 particle Substances 0.000 claims description 52
- 238000005096 rolling process Methods 0.000 claims description 12
- 239000003814 drug Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 229940124597 therapeutic agent Drugs 0.000 claims description 7
- 239000000443 aerosol Substances 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- -1 taggant Substances 0.000 claims description 4
- 239000002872 contrast media Substances 0.000 claims description 3
- 239000000032 diagnostic agent Substances 0.000 claims description 3
- 229940039227 diagnostic agent Drugs 0.000 claims description 3
- 239000003124 biologic agent Substances 0.000 claims description 2
- 210000003169 central nervous system Anatomy 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 239000000696 magnetic material Substances 0.000 claims description 2
- 239000002907 paramagnetic material Substances 0.000 claims description 2
- 238000005191 phase separation Methods 0.000 claims description 2
- 230000002685 pulmonary effect Effects 0.000 claims description 2
- 230000019491 signal transduction Effects 0.000 claims description 2
- 238000000034 method Methods 0.000 description 7
- 239000011344 liquid material Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22513809P | 2009-07-13 | 2009-07-13 | |
| US61/225,138 | 2009-07-13 | ||
| PCT/US2010/041797 WO2011008737A2 (en) | 2009-07-13 | 2010-07-13 | Engineered aerosol particles, and associated methods |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014182213A Division JP6189807B2 (ja) | 2009-07-13 | 2014-09-08 | 工学的に作製されたエアロゾル粒子、およびそれに関連した方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012532739A JP2012532739A (ja) | 2012-12-20 |
| JP2012532739A5 true JP2012532739A5 (https=) | 2013-08-15 |
| JP5656996B2 JP5656996B2 (ja) | 2015-01-21 |
Family
ID=42818752
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012520713A Expired - Fee Related JP5656996B2 (ja) | 2009-07-13 | 2010-07-13 | 工学的に作製されたエアロゾル粒子、およびそれに関連した方法 |
| JP2014182213A Active JP6189807B2 (ja) | 2009-07-13 | 2014-09-08 | 工学的に作製されたエアロゾル粒子、およびそれに関連した方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014182213A Active JP6189807B2 (ja) | 2009-07-13 | 2014-09-08 | 工学的に作製されたエアロゾル粒子、およびそれに関連した方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20120114554A1 (https=) |
| EP (1) | EP2454011A2 (https=) |
| JP (2) | JP5656996B2 (https=) |
| WO (1) | WO2011008737A2 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9057712B1 (en) | 2011-10-27 | 2015-06-16 | Copilot Ventures Fund Iii Llc | Methods of delivery of encapsulated perfluorocarbon taggants |
| WO2013082111A2 (en) * | 2011-11-29 | 2013-06-06 | The University Of North Carolina At Chapel Hill | Geometrically engineered particles and methods for modulating macrophage or immune responses |
| EP3286245A4 (en) * | 2015-04-21 | 2018-09-19 | Ran Biotechnologies, Inc. | Novel fluorinated surfactants |
| TW201722965A (zh) | 2015-08-16 | 2017-07-01 | 葛蘭素史密斯克藍智慧財產發展有限公司 | 用於抗菌應用之化合物 |
| WO2017035408A1 (en) | 2015-08-26 | 2017-03-02 | Achillion Pharmaceuticals, Inc. | Compounds for treatment of immune and inflammatory disorders |
| AR106018A1 (es) | 2015-08-26 | 2017-12-06 | Achillion Pharmaceuticals Inc | Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos |
| CN108348470A (zh) | 2015-11-18 | 2018-07-31 | 葛兰素史克知识产权第二有限公司 | 利巴韦林的药物组合物 |
| CN109039582A (zh) * | 2016-04-28 | 2018-12-18 | 王志 | 一种输出Lorenz型吸引子的简单混沌系统电路 |
| IL262720B2 (en) | 2016-05-05 | 2024-06-01 | Liquidia Tech Inc | Dry powder treprostinil for the treatment of pulmonary hypertension |
| CN109790143A (zh) | 2016-05-10 | 2019-05-21 | C4医药公司 | 用于靶蛋白降解的胺连接的c3-戊二酰亚胺降解决定子体 |
| SG11201811491YA (en) | 2016-06-27 | 2019-01-30 | Achillion Pharmaceuticals Inc | Quinazoline and indole compounds to treat medical disorders |
| CN110603252A (zh) | 2017-03-01 | 2019-12-20 | 艾其林医药公司 | 用于治疗医学障碍的芳基、杂芳基和杂环药物化合物 |
| CN110769822A (zh) | 2017-06-20 | 2020-02-07 | C4医药公司 | 用于蛋白降解的n/o-连接的降解决定子和降解决定子体 |
| EP3773576A4 (en) | 2018-03-26 | 2021-12-29 | C4 Therapeutics, Inc. | Cereblon binders for the degradation of ikaros |
| US20230022157A1 (en) | 2018-08-20 | 2023-01-26 | Achillion Pharmaceuticals, Inc. | Pharmaceutical compounds for the treatment of complement factor d medical disorders |
| JP7443375B2 (ja) | 2018-09-06 | 2024-03-05 | アキリオン ファーマシューティカルズ， インコーポレーテッド | 医学的障害の治療のための大環状化合物 |
| EP3866773B1 (en) | 2018-10-16 | 2024-08-28 | Georgia State University Research Foundation, Inc. | Carbon monoxide prodrugs for the treatment of medical disorders |
| CN115362162A (zh) | 2020-02-20 | 2022-11-18 | 艾其林医药公司 | 用于治疗补体因子d介导的障碍的杂芳基化合物 |
| TW202146412A (zh) | 2020-03-05 | 2021-12-16 | 美商Ｃ４醫藥公司 | 用於標靶降解brd9之化合物 |
| CN116437913A (zh) | 2020-09-23 | 2023-07-14 | 艾其林医药公司 | 用于治疗补体介导的病症的药物化合物 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5399363A (en) | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
| AU6130394A (en) | 1991-03-05 | 1994-08-15 | Miris Medical Corporation | Apparatus for providing a timed release of an amount of aerosol medication |
| DE69230613T2 (de) | 1991-07-02 | 2000-12-28 | Inhale Inc | Verfahren und vorrichtung zum abgeben von medikamenten in aerosolform |
| US5785049A (en) | 1994-09-21 | 1998-07-28 | Inhale Therapeutic Systems | Method and apparatus for dispersion of dry powder medicaments |
| US5558085A (en) | 1993-01-29 | 1996-09-24 | Aradigm Corporation | Intrapulmonary delivery of peptide drugs |
| US5934272A (en) | 1993-01-29 | 1999-08-10 | Aradigm Corporation | Device and method of creating aerosolized mist of respiratory drug |
| US5497763A (en) | 1993-05-21 | 1996-03-12 | Aradigm Corporation | Disposable package for intrapulmonary delivery of aerosolized formulations |
| NZ293163A (en) | 1994-09-21 | 1998-09-24 | Inhale Therapeutic Syst | Inhalation medicament disperser, aerosol from high pressure gas entrainment of fluidised powder drawn from receptacle feed tube |
| US5780014A (en) | 1995-04-14 | 1998-07-14 | Inhale Therapeutic Systems | Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin |
| KR100845565B1 (ko) * | 2003-12-01 | 2008-07-10 | 더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이 | 나노스케일 3차원 구조물의 제조방법 및 장치 |
| WO2007030698A2 (en) * | 2005-09-07 | 2007-03-15 | The University Of North Carolina At Chapel Hill | Materials and methods for fabricating isolated micro-and nano-structures having chemical functionality |
| MXPA06006738A (es) | 2003-12-19 | 2006-08-31 | Univ North Carolina | Metodos para fabricar micro- y nano-estructuras aisladas utilizando litografia suave o de impresion. |
| WO2006130943A1 (en) * | 2005-06-10 | 2006-12-14 | The Governors Of The University Of Alberta | Respirable dried powder formulation comprising drug loaded nanoparticles |
| CN102016814B (zh) * | 2005-06-17 | 2013-10-23 | 北卡罗来纳大学查珀尔希尔分校 | 纳米粒子制备方法、系统及材料 |
| WO2007094829A2 (en) * | 2005-11-07 | 2007-08-23 | The University Of North Carolina At Chapel Hill | Isolated and fixed micro and nano structures and methods thereof |
| WO2008011051A1 (en) * | 2006-07-17 | 2008-01-24 | Liquidia Technologies, Inc. | Nanoparticle fabrication methods, systems, and materials |
| WO2008027571A2 (en) * | 2006-08-30 | 2008-03-06 | Liquidia Technologies, Inc. | Nanoparticles having functional additives for self and directed assembly and methods of fabricating same |
| US7875654B2 (en) * | 2007-03-23 | 2011-01-25 | The Board Of Trustees Of The University Of Illinois | System for forming janus particles |
-
2010
- 2010-07-13 JP JP2012520713A patent/JP5656996B2/ja not_active Expired - Fee Related
- 2010-07-13 US US13/383,518 patent/US20120114554A1/en not_active Abandoned
- 2010-07-13 EP EP10742329A patent/EP2454011A2/en not_active Ceased
- 2010-07-13 WO PCT/US2010/041797 patent/WO2011008737A2/en not_active Ceased
-
2014
- 2014-09-08 JP JP2014182213A patent/JP6189807B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012532739A5 (https=) | ||
| JP6189807B2 (ja) | 工学的に作製されたエアロゾル粒子、およびそれに関連した方法 | |
| Malamatari et al. | Spray drying for the preparation of nanoparticle-based drug formulations as dry powders for inhalation | |
| Heng et al. | The nano spray dryer B-90 | |
| Paris et al. | Mesoporous silica nanoparticles for co-delivery of drugs and nucleic acids in oncology: A review | |
| Peng et al. | Nano-formulations for pulmonary delivery: Past, present, and future perspectives | |
| Oberdörster et al. | Nanoparticles and the brain: cause for concern? | |
| CN101479051B (zh) | 生产多层粒子、纤维和喷雾的系统和方法以及施用它们的方法 | |
| Anton et al. | Trojan microparticles for drug delivery | |
| ATE287257T1 (de) | Zubereitung von partikelhaltigen arzneimitteln zur inhalation | |
| Garello et al. | Micro/nanosystems for magnetic targeted delivery of bioagents | |
| CN108578372A (zh) | 微晶二酮哌嗪组合物以及方法 | |
| Rogueda et al. | The nanoscale in pulmonary delivery. Part 2: formulation platforms | |
| Dua et al. | Targeting microRNAs using nanotechnology in pulmonary diseases. | |
| Tomoda et al. | Preparation and properties of inhalable nanocomposite particles: effects of the temperature at a spray-dryer inlet upon the properties of particles | |
| Negi et al. | Engineering inhalable therapeutic particles: conventional and emerging approaches | |
| Du et al. | Breath and beyond: advances in nanomedicine for oral and intranasal aerosol drug delivery | |
| Keil et al. | Evaluation of adsorption of DNA/PEI polyplexes to tubing materials | |
| Kwak et al. | Microfluidic Platforms for Ex Vivo and In Vivo Gene Therapy | |
| CN102365126B (zh) | 用于生产包覆粒子的工艺和设备 | |
| Pawara et al. | Spray Dried Nanoparticle for Pulmonary Delivery: Current Developments and Future Perspectives. | |
| Dangova et al. | Nanocarriers-assisted nose-to-brain delivery of levodopa: Current progress and prospects | |
| Donovan et al. | Novel dry powder inhaler particle-dispersion systems | |
| Biesel et al. | Soft mist inhaler nebulization by Rayleigh-breakup largely preserves functional integrity of liposomal mRNA in respirable aerosols | |
| WO2018150593A1 (ja) | 吸入装置 |